President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine

Ibogaine is banned under the federal government's most restrictive category for illegal, high-risk drugs.

President Donald Trump signed an executive order Saturday to accelerate research for some psychedelic drugs to treat mental health disorders.

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.